{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T05:12:22Z","timestamp":1779340342658,"version":"3.51.4"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Acute thyrotoxic myopathy (ATM) is a relatively rare and severe complication of hyperthyroidism, mainly reported in individual cases and lacking standardized treatment protocols.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study evaluated the efficacy of glucocorticoids (GCs), adenosine triphosphate (ATP), and antithyroid drugs (ATDs) in treating ATM to guide clinical management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively analyzed 42 ATM patients treated with GCs, ATP, and ATDs. The Acute Thyrotoxic Myopathy Symptom Score (ATMSS) was applied to evaluate efficacy at baseline (T0), day 7 (T7), and day 28 (T28) of treatment. Binary logistic regression was used to identify predictors of therapeutic efficacy, examining the impact of pre-treatment biochemical indicators and ATMSS on symptom relief (R) at T7 and complete remission (CR) at T28.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>\n                      ATMSS demonstrated significant improvement at both T7 and T28 (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0&amp;lt;\u00a00.001). R and CR rates differed among symptoms, with nasal reflux, dysphagia, and dyspnea showing markedly higher rates than dysarthria, gag reflex, and muscle weakness (T7: \u03c7\u00b2 = 30.89, T28: \u03c7\u00b2 = 36.71, both\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt;\u00a00.001). Binary logistic regression analysis indicated that higher baseline dysarthria scores were associated with lower R rates at T7 (\n                      <jats:italic>OR<\/jats:italic>\n                      =\u00a00.216, 95%\n                      <jats:italic>CI<\/jats:italic>\n                      \u00a0=\u00a00.056\u20130.836,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.027), while more severe muscle weakness at T7 predicted lower CR at T28 (\n                      <jats:italic>OR<\/jats:italic>\n                      \u00a0=\u00a00.564, 95%\n                      <jats:italic>CI<\/jats:italic>\n                      \u00a0=\u00a00.323\u20130.984,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.044).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The combination of GCs, ATP, and ATDs effectively alleviated the ATMSS in the short (7day) and medium (28day) term. However, recovery rates differ among symptoms. Specifically, dysarthria at baseline and muscle weakness at T7 showed significant predictive value for treatment outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1769220","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T04:52:59Z","timestamp":1779339179000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Therapeutic efficacy of glucocorticoids, ATP, and antithyroid drugs in acute thyrotoxic myopathy: evaluation using the acute thyrotoxic myopathy symptom score"],"prefix":"10.3389","volume":"17","author":[{"given":"Qiaoli","family":"Li","sequence":"first","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuelan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zien","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, China"]},{"name":"Department of Endocrinology, Affiliated Hengyang Hospital of Hunan Normal University and Hengyang Central Hospital","place":["Hengyang, Hunan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaqi","family":"Kuang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunjiao","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, China"]},{"name":"Department of Pathology, The People\u2019s Hospital of Guangxi Zhuang Autonomous Region and Guangxi Academy of Medical Sciences","place":["Nanning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shien","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingliang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, China"]},{"name":"Department of Endocrinology and Metabolism, Binzhou Medical University Hospital","place":["Binzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuping","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenxing","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyan","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Xian","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinghuan","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingfen","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuojie","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4236\/ojmip.2017.72002","article-title":"Differential diagnosis of thyrotoxic myopathy","volume":"7","author":"Kazakov","year":"2017","journal-title":"Open J Mol Integr Physiol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.5603\/EP.a2022.0004","article-title":"Thyrotoxic myopathy: research status, diagnosis, and treatment","volume":"73","author":"Cui","year":"2022","journal-title":"Endokrynol Pol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s00455-003-0510-z","article-title":"Dysphagia as a manifestation of thyrotoxicosis: report of three cases and literature review","volume":"19","author":"Chiu","year":"2004","journal-title":"Dysphagia"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/929523","article-title":"Thyrotoxic dysphagia in an 82-year-old male","volume":"2011","author":"Parperis","year":"2011","journal-title":"Case Rep Med"},{"key":"B5","article-title":"Thyrotoxicosis presenting as acute bulbar palsy","volume":"59","author":"Mathew","year":"2011","journal-title":"J Assoc Physicians India"},{"key":"B6","doi-asserted-by":"publisher","first-page":"21\u20130715","DOI":"10.1530\/edm-21-0175","article-title":"Myopathic dysphagia caused by thyrotoxicosis: a case report and review of the literature","volume":"2022","author":"Alwithenani","year":"2022","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.39.472","article-title":"Hyperthyroidism presenting as dysphagia","volume":"39","author":"Noto","year":"2000","journal-title":"Intern Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1159\/000528357","article-title":"Tsab modulates microglia M1 polarization via activation of the Tshr-mediated Nf-Kb signaling pathway","volume":"113","author":"Liu","year":"2023","journal-title":"Neuroendocrinology"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/cphy.c150019","article-title":"Mitochondrial actions of thyroid hormone","volume":"6","author":"Lanni","year":"2016","journal-title":"Compr Physiol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.44.511.385","article-title":"Thyrotoxic muscle disease","volume":"44","author":"Ramsay","year":"1968","journal-title":"Postgrad Med J"},{"key":"B11","doi-asserted-by":"publisher","first-page":"6945239","DOI":"10.1155\/ije\/6945239","article-title":"Diagnostic value and clinical validation of acute thyrotoxic myopathy symptom score in acute thyrotoxic myopathy","volume":"2025","author":"Zhang","year":"2025","journal-title":"Int J Endocrinol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)42522-5","article-title":"Acute hydrologic bulbar palsy","volume":"43","author":"Lpe","year":"1944","journal-title":"Lancet"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-024-01016-5","article-title":"Graves disease: latest understanding of pathogenesis and treatment options","volume":"20","author":"Lanzolla","year":"2024","journal-title":"Nat Rev Endocrinol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"8467","DOI":"10.1038\/s41598-025-93522-3","article-title":"Elevated serum Cd40 as a potential biomarker for the differential diagnosis of acute thyrotoxic myopathy","volume":"15","author":"Wu","year":"2025","journal-title":"Sci Rep"},{"key":"B15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1080\/17446651.2023.2167709","article-title":"Non-thionamide antithyroid drug options in Graves' hyperthyroidism","volume":"18","author":"Ruslan","year":"2023","journal-title":"Expert Rev Endocrinol Metab"},{"key":"B16","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12964-025-02266-0","article-title":"The immunosuppressive effect of glucocorticoids in human primary T cells is mainly mediated via a rapid inhibition of the Il-2\/Il-2r signaling axis","volume":"23","author":"Albarracin Melo","year":"2025","journal-title":"Cell Commun Signal"},{"key":"B17","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1210\/endrev\/bnae008","article-title":"The glucocorticoid receptor: isoforms, functions, and contribution to glucocorticoid sensitivity","volume":"45","author":"Lockett","year":"2024","journal-title":"Endocr Rev"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01026","article-title":"Glucocorticoids impair phagocytosis and inflammatory response against Crohn's disease-associated adherent-invasive Escherichia coli","volume":"9","author":"Olivares-Morales","year":"2018","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1177\/2042018820958335","article-title":"Glucocorticoids in Graves' orbitopathy: mechanisms of action and clinical application","volume":"11","author":"L\u00e4ngericht","year":"2020","journal-title":"Ther Adv Endocrinol Metab"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(23)02016-0","article-title":"Hyperthyroidism","volume":"403","author":"Chaker","year":"2024","journal-title":"Lancet"},{"key":"B21","doi-asserted-by":"publisher","first-page":"4575","DOI":"10.1038\/s41467-022-32110-9","article-title":"Multistep orthophosphate release tunes actomyosin energy transduction","volume":"13","author":"Moretto","year":"2022","journal-title":"Nat Commun"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2024.104283","article-title":"Repairing muscle with broccoli-derived sulforaphane: a preclinical evaluation for the treatment of mitochondrial myopathies","volume":"30","author":"Lilley","year":"2025","journal-title":"Drug Discov Today"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1039\/d3sc03612j","article-title":"Toward a molecular mechanism for the interaction of Atp with alpha-synuclein","volume":"14","author":"Kamski-Hennekam","year":"2023","journal-title":"Chem Sci"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.0c13118","article-title":"Effects of weak nonspecific interactions with Atp on proteins","volume":"143","author":"Nishizawa","year":"2021","journal-title":"J Am Chem Soc"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.4c01140","article-title":"Atomistic insights into the stabilization of Tdp-43 protofibrils by Atp","volume":"64","author":"Xu","year":"2024","journal-title":"J Chem Inf Model"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12889","article-title":"Immunometabolic signatures predict recovery from thyrotoxic myopathy in patients with Graves' disease","volume":"13","author":"Setoyama","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(74)90477-x","article-title":"Acute bulbar muscle dysfunction and hyperthyroidism. A study of four cases and review of the literature","volume":"56","author":"Kammer","year":"1974","journal-title":"Am J Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000209282","article-title":"Pearls & Oy-sters: thyroid-associated ophthalmopathy and transient neuromuscular junction disorder due to Graves disease","volume":"102","author":"Zouvelou","year":"2024","journal-title":"Neurology"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbmt.2024.10.029","article-title":"Comparison of exercise capacity and physical activity in patients with hyperthyroidism and controls","volume":"40","author":"Y\u0131lmaz","year":"2024","journal-title":"J Bodyw Mov Ther"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/369807","article-title":"Acute thyrotoxic bulbar myopathy with encephalopathic behaviour: an uncommon complication of hyperthyroidism","volume":"2013","author":"Boddu","year":"2013","journal-title":"Case Rep Endocrinol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-2126989\/v1","article-title":"Acute thyrotoxic myopathy combined with neck pain: a case report","volume":"44","author":"Fu","year":"2023","journal-title":"Neuro Endocrinol Lett"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1177\/02841851241280115","article-title":"Abnormal brain regional activity in acute thyrotoxic myopathy assessed by resting-state functional Mri","volume":"65","author":"Kuang","year":"2024","journal-title":"Acta Radiol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.15386\/cjmed-671","article-title":"Respiratory manifestations in endocrine diseases","volume":"89","author":"Lencu","year":"2016","journal-title":"Clujul Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.14309\/crj.0000000000001668","article-title":"Thyrotoxicosis-induced myopathic dysphagia treated with plasmapheresis","volume":"12","author":"Andrews","year":"2025","journal-title":"ACG Case Rep J"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1769220\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T04:53:14Z","timestamp":1779339194000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1769220\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":34,"alternative-id":["10.3389\/fendo.2026.1769220"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1769220","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"article-number":"1769220"}}